Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CASP6 | P55212 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.51 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.51 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.43 |
| ▸ | NSD2 | O96028 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29610078 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL152377 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL31229304 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL30566330 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL591403 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL29429619 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL11426413 | 1.00 | NT5E (0.68) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| Hydrochloric Acid SCHEMBL8219485 | 0.98 | NT5E (0.66) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL2730683 | 0.98 | NT5E (0.66) | NT5EALDH1A1CASP6HSD17B10CYP2C9 | |
| SCHEMBL11426409 | 0.98 | NT5E (0.66) | NT5EALDH1A1CASP6HSD17B10CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3737753-B1 | USE OF TRI- AND TETRA-HYDROXYL QUATERNARY AMMONIUM COMPOUNDS AS RESOLVING AGENTS FOR ELECTROPHORESITIC SEPARATIONS | AGILENT TECHNOLOGIES INC (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-3684941-B1 | USE OF POLYAMINES AS RESOLVING AGENTS FOR CAPILLARY ELECTROPHORESIS OF LABELED GLYCANS USING GELS | AGILENT TECHNOLOGIES INC (US) | 2025-05-14 | — | — | EP | disclosed |
| CN-111566210-B | Use of tri-and tetra-hydroxy quaternary ammonium compounds as resolving agents for electrophoretic separation | 安捷伦科技有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-111108209-B | Use of polyamines as separating agents in gel-based capillary electrophoresis with labeled glycans | 安捷伦科技有限公司 | 2024-09-20 | — | — | CN | disclosed |
| US-11988633-B2 | Use of polyamines as resolving agents for capillary electrophoresis of labeled glycans using gels | AGILENT TECHNOLOGIES, INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-11815488-B2 | Use of tri- and tetra-hydroxyl quaternary ammonium compounds as resolving agents for electrophoretic separations | AGILENT TECHNOLOGIES, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| US-20210063347-A1 | USE OF POLYAMINES AS RESOLVING AGENTS FOR CAPILLARY ELECTROPHORESIS OF LABELED GLYCANS USING GELS | AGILENT TECHNOLOGIES, INC. (US) | 2021-03-04 | — | — | US | disclosed |
| US-20200371063-A1 | Use of Tri- and Tetra- Hydroxyl Quaternary Ammonium Compounds As Resolving Agents for Electrophoretic Separations | AGILENT TECHNOLOGIES, INC. (US) | 2020-11-26 | — | — | US | disclosed |
| EP-3737753-A1 | USE OF TRI- AND TETRA-HYDROXYL QUATERNARY AMMONIUM COMPOUNDS AS RESOLVING AGENTS FOR ELECTROPHORESITIC SEPARATIONS | Agilent Technologies, Inc. (US) | 2020-11-18 | — | — | EP | disclosed |
| CN-111566210-A | Use of trihydroxy and tetrahydroxy quaternary ammonium compounds as resolving agents for electrophoretic separations | 安捷伦科技有限公司 | 2020-08-21 | — | — | CN | disclosed |
| EP-3684941-A2 | USE OF POLYAMINES AS RESOLVING AGENTS FOR CAPILLARY ELECTROPHORESIS OF LABELED GLYCANS USING GELS | Prozyme, Inc. (US) | 2020-07-29 | — | — | EP | disclosed |
| CN-111108209-A | Use of polyamines as separating agents in gel-based capillary electrophoresis with labeled glycans | 安捷伦科技有限公司 | 2020-05-05 | — | — | CN | disclosed |
| WO-2019060633-A2 | USE OF POLYAMINES AS RESOLVING AGENTS FOR CAPILLARY ELECTROPHORESIS OF LABELED GLYCANS USING GELS | PROZYME, INC. (US) | 2019-03-28 | — | — | WO | disclosed |
| US-8796323-B2 | Defensin-like molecules as novel antimicrobial agents | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2014-08-05 | — | — | US | disclosed |
| US-20130231376-A1 | DEFENSIN-LIKE MOLECULES AS NOVEL ANTIMICROBIAL AGENTS | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2013-09-05 | — | — | US | disclosed |
| WO-2012061767-A2 | DEFENSIN-LIKE MOLECULES AS NOVEL ANTIMICROBIAL AGENTS | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2012-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231376-A1 | DEFENSIN-LIKE MOLECULES AS NOVEL ANTIMICROBIAL AGENTS | DBNL, DNASE1L3, STING1 | NT5E 452/4885ALDH1A1 2828/4885CASP6 1573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.